Baseline PSA ≥ 20 ng/mL (p < 0.0001), metastatic disease at baseline (p < 0.0001), and former or current smoker (p = 0.0284) were independently significant risk factors for CRFS events. The gene discussed is KLK3; the disease is metastatic neoplasm.